
Robert A. Schwartzman
Examiner (ID: 19178)
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1805 |
| Total Applications | 441 |
| Issued Applications | 346 |
| Pending Applications | 61 |
| Abandoned Applications | 34 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3882215
[patent_doc_number] => 05776675
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Identification of compounds modulating protein/cell membrane association'
[patent_app_type] => 1
[patent_app_number] => 8/446856
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 9
[patent_no_of_words] => 8321
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776675.pdf
[firstpage_image] =>[orig_patent_app_number] => 446856
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/446856 | Identification of compounds modulating protein/cell membrane association | Jun 4, 1995 | Issued |
Array
(
[id] => 4001196
[patent_doc_number] => 05888502
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-30
[patent_title] => 'Recombinant retroviruses'
[patent_app_type] => 1
[patent_app_number] => 8/463122
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 31
[patent_no_of_words] => 23799
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/888/05888502.pdf
[firstpage_image] =>[orig_patent_app_number] => 463122
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/463122 | Recombinant retroviruses | Jun 4, 1995 | Issued |
Array
(
[id] => 3764843
[patent_doc_number] => 05733548
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-31
[patent_title] => 'Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments'
[patent_app_type] => 1
[patent_app_number] => 8/464318
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9208
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/733/05733548.pdf
[firstpage_image] =>[orig_patent_app_number] => 464318
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/464318 | Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments | Jun 4, 1995 | Issued |
Array
(
[id] => 3624986
[patent_doc_number] => 05689046
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-11-18
[patent_title] => 'Stilbene synthase gene'
[patent_app_type] => 1
[patent_app_number] => 8/461901
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 11120
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/689/05689046.pdf
[firstpage_image] =>[orig_patent_app_number] => 461901
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461901 | Stilbene synthase gene | Jun 4, 1995 | Issued |
Array
(
[id] => 3744509
[patent_doc_number] => 05716832
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-02-10
[patent_title] => 'Packaging cells'
[patent_app_type] => 1
[patent_app_number] => 8/462492
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13622
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/716/05716832.pdf
[firstpage_image] =>[orig_patent_app_number] => 462492
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462492 | Packaging cells | Jun 4, 1995 | Issued |
Array
(
[id] => 3828906
[patent_doc_number] => 05739107
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-14
[patent_title] => 'Morphogen treatment of gastrointestinal ulcers'
[patent_app_type] => 1
[patent_app_number] => 8/462623
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 22566
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/739/05739107.pdf
[firstpage_image] =>[orig_patent_app_number] => 462623
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/462623 | Morphogen treatment of gastrointestinal ulcers | Jun 4, 1995 | Issued |
Array
(
[id] => 4072511
[patent_doc_number] => 05965435
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-12
[patent_title] => 'Viral nucleotide sequences'
[patent_app_type] => 1
[patent_app_number] => 8/460257
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 7689
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/965/05965435.pdf
[firstpage_image] =>[orig_patent_app_number] => 460257
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460257 | Viral nucleotide sequences | Jun 1, 1995 | Issued |
Array
(
[id] => 4182082
[patent_doc_number] => 06159735
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Calcitonin/calcitonin gene related peptide enhancer element and associated DNA binding proteins'
[patent_app_type] => 1
[patent_app_number] => 8/457996
[patent_app_country] => US
[patent_app_date] => 1995-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 29
[patent_no_of_words] => 14835
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159735.pdf
[firstpage_image] =>[orig_patent_app_number] => 457996
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/457996 | Calcitonin/calcitonin gene related peptide enhancer element and associated DNA binding proteins | May 31, 1995 | Issued |
Array
(
[id] => 3955738
[patent_doc_number] => 05935934
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => 'Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy'
[patent_app_type] => 1
[patent_app_number] => 8/454418
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 10716
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/935/05935934.pdf
[firstpage_image] =>[orig_patent_app_number] => 454418
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/454418 | Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy | May 29, 1995 | Issued |
Array
(
[id] => 3768111
[patent_doc_number] => 05733761
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-31
[patent_title] => 'Protein production and protein delivery'
[patent_app_type] => 1
[patent_app_number] => 8/451893
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 19729
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/733/05733761.pdf
[firstpage_image] =>[orig_patent_app_number] => 451893
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451893 | Protein production and protein delivery | May 25, 1995 | Issued |
Array
(
[id] => 3759048
[patent_doc_number] => 05741641
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-04-21
[patent_title] => 'Morphogenic protein screening method'
[patent_app_type] => 1
[patent_app_number] => 8/451953
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18182
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/741/05741641.pdf
[firstpage_image] =>[orig_patent_app_number] => 451953
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451953 | Morphogenic protein screening method | May 25, 1995 | Issued |
Array
(
[id] => 3726040
[patent_doc_number] => 05702916
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Biological Containment'
[patent_app_type] => 1
[patent_app_number] => 8/449958
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 34
[patent_no_of_words] => 26258
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/702/05702916.pdf
[firstpage_image] =>[orig_patent_app_number] => 449958
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/449958 | Biological Containment | May 24, 1995 | Issued |
Array
(
[id] => 4190441
[patent_doc_number] => 06043088
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'Prostate/colon tumor suppressor gene located on human chromosome 8'
[patent_app_type] => 1
[patent_app_number] => 8/445515
[patent_app_country] => US
[patent_app_date] => 1995-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 28
[patent_no_of_words] => 28405
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043088.pdf
[firstpage_image] =>[orig_patent_app_number] => 445515
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/445515 | Prostate/colon tumor suppressor gene located on human chromosome 8 | May 21, 1995 | Issued |
Array
(
[id] => 3693634
[patent_doc_number] => 05661002
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => 'Modified transcription control unit and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/446126
[patent_app_country] => US
[patent_app_date] => 1995-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24906
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/661/05661002.pdf
[firstpage_image] =>[orig_patent_app_number] => 446126
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/446126 | Modified transcription control unit and uses thereof | May 18, 1995 | Issued |
Array
(
[id] => 3814434
[patent_doc_number] => 05770434
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-23
[patent_title] => 'Soluble peptides having constrained, secondary conformation in solution and method of making same'
[patent_app_type] => 1
[patent_app_number] => 8/440787
[patent_app_country] => US
[patent_app_date] => 1995-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 28247
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/770/05770434.pdf
[firstpage_image] =>[orig_patent_app_number] => 440787
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/440787 | Soluble peptides having constrained, secondary conformation in solution and method of making same | May 14, 1995 | Issued |
Array
(
[id] => 4045430
[patent_doc_number] => 05869305
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-09
[patent_title] => 'Recombinant viral vector system'
[patent_app_type] => 1
[patent_app_number] => 8/440738
[patent_app_country] => US
[patent_app_date] => 1995-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 9550
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/869/05869305.pdf
[firstpage_image] =>[orig_patent_app_number] => 440738
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/440738 | Recombinant viral vector system | May 14, 1995 | Issued |
Array
(
[id] => 3932475
[patent_doc_number] => 05972597
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Methods using modified vaccinia virus'
[patent_app_type] => 1
[patent_app_number] => 8/456023
[patent_app_country] => US
[patent_app_date] => 1995-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 51
[patent_no_of_words] => 33602
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972597.pdf
[firstpage_image] =>[orig_patent_app_number] => 456023
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/456023 | Methods using modified vaccinia virus | May 12, 1995 | Issued |
Array
(
[id] => 3884065
[patent_doc_number] => 05723287
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-03
[patent_title] => 'Recombinant viruses displaying a nonviral polypeptide on their external surface'
[patent_app_type] => 1
[patent_app_number] => 8/381960
[patent_app_country] => US
[patent_app_date] => 1995-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19494
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/723/05723287.pdf
[firstpage_image] =>[orig_patent_app_number] => 381960
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/381960 | Recombinant viruses displaying a nonviral polypeptide on their external surface | May 2, 1995 | Issued |
Array
(
[id] => 4045834
[patent_doc_number] => 05869333
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-09
[patent_title] => 'Ryegrass pollen allergen'
[patent_app_type] => 1
[patent_app_number] => 8/433885
[patent_app_country] => US
[patent_app_date] => 1995-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 43
[patent_no_of_words] => 28271
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/869/05869333.pdf
[firstpage_image] =>[orig_patent_app_number] => 433885
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/433885 | Ryegrass pollen allergen | May 1, 1995 | Issued |
Array
(
[id] => 3659602
[patent_doc_number] => 05648247
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-07-15
[patent_title] => 'Method for increasing the omega-hydroxylase activity in candida tropicals'
[patent_app_type] => 1
[patent_app_number] => 8/425124
[patent_app_country] => US
[patent_app_date] => 1995-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10559
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/648/05648247.pdf
[firstpage_image] =>[orig_patent_app_number] => 425124
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/425124 | Method for increasing the omega-hydroxylase activity in candida tropicals | Apr 18, 1995 | Issued |